Evidence map›Paper›PMID 27882817›Full record

ArticleRenal failure2017

H

Yan Li, Lin Li, Ou Zeng, Jun Mao Liu, Jun Yang

Open access · goldAbstract read
In one paragraph

Article in Renal failure, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Recent Advances in Molecular Research on Hydrogen Sulfide (HInternational journal of molecular sciences · 2022
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. TelmisartanFrontiers in pharmacology · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. H2S improves doxorubicin-induced myocardial fibrosis by inhibiting oxidative stress and apoptosis via Keap1-Nrf2.Technology and health care : official journal of the European Society for Engineering and Medicine · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yan Lia Cardiovascular Department , The First Affiliated Hospital of the University of South China , Hengyang , Hunan , PR China.
Lin Lia Cardiovascular Department , The First Affiliated Hospital of the University of South China , Hengyang , Hunan , PR China.
Ou Zenga Cardiovascular Department , The First Affiliated Hospital of the University of South China , Hengyang , Hunan , PR China.
Jun Mao Liua Cardiovascular Department , The First Affiliated Hospital of the University of South China , Hengyang , Hunan , PR China.
Jun Yanga Cardiovascular Department , The First Affiliated Hospital of the University of South China , Hengyang , Hunan , PR China.
First Affiliated Hospital of University of South China · CNUniversity of South China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephropathy develops in many patients with type 1 diabetes mellitus (T1DM). However, the specific mechanisms and therapies remain unclear. For this purpose we investigated the effects of hydrogen sulfide (H

Indexed as

AnimalsCollagen Type IDiabetes Mellitus, ExperimentalDiabetic NephropathiesFibrosisHydrogen SulfideKidneyMaleMatrix MetalloproteinasesRandom AllocationRatsRats, Sprague-DawleySignal TransductionStreptozocinTissue Inhibitor of Metalloproteinase-1Transforming Growth Factor beta1Collagen Type IHydrogen SulfideMatrix MetalloproteinasesStreptozocinTgfb1 protein, ratTissue Inhibitor of Metalloproteinase-1Transforming Growth Factor beta1diabetic renal fibrosisextracellular signal-regulated kinase-1/2Hydrogen sulfidematrix metalloproteinases/tissue inhibitors of metalloproteinasestransforming growth factor beta 1

Identifiers

PMID27882817
PMCPMC6014487
OpenAlexW2555662400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.